Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ArcticZymes Technologies Board/Management Information 2023

Mar 22, 2023

3538_iss_2023-03-22_ad032079-2ae9-418e-b5ce-519fa5be9ee5.html

Board/Management Information

Open in viewer

Opens in your device viewer

ArcticZymes Technologies announces CEO resignation

ArcticZymes Technologies announces CEO resignation

Tromsø, March 22nd 2023 - ArcticZymes Technologies ASA (OSE: AZT) announces that

the Board of Directors has today accepted the voluntary resignation of Jethro

Holter as Chief Executive Officer, due to personal reasons.

The resignation will take effect on 30th September 2023 after the required 6

months notice period.

"On behalf of the Board, I want to thank Jethro very much for his outstanding

contributions to ArcticZymes over the past 3 years that he has served as our

CEO. During that time, Jethro has been instrumental in transforming ArcticZymes

into a successful and highly profitable business," said Marie Roskrow. "All of

the employees of ArcticZymes send their good wishes and thanks to Jethro."

The Board of Directors will immediately initiate a search for a new CEO. In the

meantime, Chairman of the Board, Marie Roskrow, will act as Executive Chairman

to lead and support the Company through this transition period.

ArcticZymes also anticipates expanding the Board of Directors in the near

future.

This information is considered to be inside information pursuant to the EU

Market Abuse Regulation and is subject to the disclosure requirements pursuant

to section 5-12 of the Norwegian Securities Trading Act.

The announcement was submitted for publication by Børge Sørvoll ,CFO at

ArcticZymes Technologies ASA, on 22 March 2023 at 10:20 CET.

For more information, please contact:

ArcticZymes Technologies

Chairman of the Board, Marie Roskrow Tel: +44 (0) 7496 959 743

[email protected]

About ArcticZymes Technologies ASA

ArcticZymes Technologies is a Norwegian life sciences company focused on the

development, manufacturing and commercialization of novel recombinant enzymes

for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing.

The company is listed on the Oslo Stock Exchange since 2005 as ArcticZymes

Technologies under the [AZT] ticker. Its headquarters are based in Tromsø,

Norway, at the SIVA Innovation Centre.

ArcticZymes Technologies' IP and capabilities are protected via a large

portfolio of patents.

For more information, please visit the website: www.arcticzymes.com.